Early use of steroids in children hospitalized for COVID-19 without MIS-C not associated with shorter length of stay
Risk for Type 1 Diabetes in Children May Rise After COVID-19
Increased risk persists for up to six months postinfection for pediatric patients aged 0 to 18 years
7 Million U.S. Women Live in Maternity Care ‘Deserts’
Report from the March of Dimes states care is actually diminishing in places where it is needed most
While Awaiting Lyme Disease Vax, Treatment Reduction Offers Benefits
Next-generation Lyme Disease treatments and vaccines continue to be in high demand in Europe and the U.S. As the geographic footprint of this vector-borne illness widens, it is estimated that 476,000 people in the U.S. and 130,000 people in Europe are impacted each year.
Recent news announced by New York-based Pfizer Inc. and France-based Valneva SE confirmed their investigational Lyme disease vaccine candidate VLA15 is progressing with a late-stage clinical trial.
CDC Will Stop Issuing Daily Updates of COVID-19 Cases, Deaths
Move is in line with efforts to wind down other COVID-19-related tools on the CDC website
$30 Million Awarded for Another Bird Flu Vaccine Candidate
A global leader in influenza prevention announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Administration for Strategic Preparedness and Response, had selected CSL Seqirus to manufacture and clinically assess a cell-based, adjuvanted pre-pandemic influenza vaccine candidate to support the U.S. government's pandemic preparedness activities.
$30 Million Awarded for Another Bird Flu Vaccine Candidate
A global leader in influenza prevention announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Administration for Strategic Preparedness and Response, had selected CSL Seqirus to manufacture and clinically assess a cell-based, adjuvanted pre-pandemic influenza vaccine candidate to support the U.S. government's pandemic preparedness activities.
Pollution Tied to Risk for Serious COVID-19 Despite Vaccination
Exposures to PM2.5 and NO2 linked to increased risk for COVID-19-related hospitalization, with and without adjustment for vaccination
SARS-CoV-2 May Not Cause Increase in Type 1 Diabetes in Children
For children aged 0 to 14 years, incidence of type 1 diabetes was 20 percent higher in 2020 to 2021 than the seven-year average
Monkeypox Outbreak Turns More Severe
While the extent of the monkeypox outbreak appears to be slowing down, the U.S Centers for Disease Control and Prevention (CDC) disclosed today that people are experiencing severe manifestations of monkeypox virus (MPX) infection.
And the CDC confirmed there are medical countermeasures available to treat people infected with monkeypox.